Volume 68 Received 7 November 2012 | ||||||||||
| ||||||||||
aDepartment of Organic Chemistry, Wroclaw Medical University, 9 Grodzka St, 50-137 Wroclaw, Poland,bDepartment of Applied Pharmacy, Wroclaw Medical Uniwersity, 38 Szewska St, 50-137 Wroclaw, Poland,cDepartment of Bioorganic Chemistry, Faculty of Engineering and Economics, Wroclaw University of Economics, 118/120 Komandorska St, 53-345 Wroclaw, Poland, and dFaculty of Chemistry, University of Wroclaw, 14 Joliot-Curie St, 50-383 Wroclaw, Poland
Correspondence e-mail: isai@o2.pl
In the title compound, C24H18Cl4N4, the pyrimidine ring makes dihedral angles of 19.1 (2), 4.1 (2) and 67.5 (2)°, respectively, with phenyl and two benzene rings, and the molecular conformation is stabilized by an intramolecular N-H
N hydrogen bond closing a six-membered ring with an S(6) motif. In the crystal, a pair of intermolecular N-H
N hydrogen bonds connect two molecules, forming inversion dimers with R22(12) motifs. C-H
interactions links the dimers into a chain running along the a-axis direction. There are also
-
stacking interactions [centroid-centroid distance = 3.666 (4) Å] between the benzene rings of adjacent chains.
For the antibacterial activity of 6-methyl-2-phenyl-5-substituted pyrimidine derivatives, see: Cieplik et al. (2003
, 2008
). For related structures, see: Cieplik et al. (2006
, 2012
).
|
|
|
|
Data collection: CrysAlis CCD (Oxford Diffraction, 2007
); cell refinement: CrysAlis CCD; data reduction: CrysAlis RED (Oxford Diffraction, 2007
); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: XP in SHELXTL (Sheldrick, 2008
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IS5217 ).
Cieplik, J., Pluta, J., Bryndal, I. & Lis, T. (2006). Acta Cryst. C62, o259-o261.
![[details]](../../../../../../c/graphics/details.gif)
Cieplik, J., Pluta, J. & Gubrynowicz, O. (2003). Boll. Chim. Farm. 142, 146-150.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Cieplik, J., Raginia, M., Pluta, J., Gubrynowicz, O., Bryndal, I. & Lis, T. (2008). Acta Pol. Pharm. Drug Res. 65, 427-434. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Cieplik, J., Stolarczyk, M., Bryndal, I. & Lis, T. (2012). Acta Cryst. E68, o1729-o1730.
![[details]](../../../../../../e/graphics/details.gif)
Oxford Diffraction (2007). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Abington, England.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)